For the Inventor, By the Inventor

Enter assignee name

Vienna, Austria

Baxter Innovations Gmbh

Calculating rank

USPTO Granted Patents = 12

% Expired Patents = 66.7

EPO Patents = 1

Forward Citations = 28

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Friedrich Dorner (8 out of 91 patents)

Manfred Reiter (6 out of 71 patents)

Wolfgang Mundt (6 out of 63 patents)

4. Hans-Peter Schwarz (4 out of 107 patents)

5. Peter Turecek (4 out of 120 patents)

6. Artur Mitterer (4 out of 53 patents)

7. Randolf Kerschbaumer (3 out of 16 patents)

8. Friedrich Scheiflinger (3 out of 76 patents)

9. Gerhard Antoine (3 out of 11 patents)

10. Miha Furlan (3 out of 13 patents)

11. Bernhard Laemmle (3 out of 7 patents)

12. Helena Elisabeth Schaller-Gerritsen (3 out of 5 patents)

13. Luigina Tagliavacca (3 out of 6 patents)

14. Klaus Zimmermann (3 out of 10 patents)

15. Leopold Grillberger (2 out of 42 patents)

12 patents: Sort by Forward Citations

1. 8722406 - Medium for the protein-free and serum-free cultivation of cells (2014-05-13),

2. 8703426 - Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV (2014-04-22),

3. 8329465 - Recombinant cell clones having increased stability and methods of making and using the same (2012-12-11),

4. 8084252 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-27),

5. 8084251 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-27),

6. 8080414 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-20),

7. 8021881 - Medium for the protein-free and serum-free cultivation of cells (2011-09-20),

8. 7910094 - Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV (2011-03-22),

9. 7648958 - Factor VIII/vWF-complex and methods of purifying same (2010-01-19),

10. 7557188 - Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide (2009-07-07),

11. 7501117 - Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV (2009-03-10),

12. 7498146 - Stable factor VIII/von willebrand factor complex (2009-03-03),

Company Overview

Baxter Innovations GmbH, based in Vienna, Austria, specializes in the development and manufacturing of advanced medical technologies and devices. The company focuses on innovative solutions that enhance patient care and improve healthcare outcomes. With a commitment to research and development, Baxter Innovations is engaged in various domains, including pharmaceuticals, biotechnology, and medical devices, aiming to address critical healthcare challenges and support healthcare professionals globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

12 Patents

#66 in Vienna

#269 in Austria

#48,334 in the World

Vienna, Austria

Baxter Innovations Gmbh

Forward Citations = 28

22 inventors:

Friedrich Dorner (8 out of 91 patents)

Manfred Reiter (6 out of 71 patents)

Wolfgang Mundt (6 out of 63 patents)

4. Hans-Peter Schwarz (4 out of 107 patents)

5. Peter Turecek (4 out of 120 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Baxter Innovations Gmbh. Retrieved from https://idiyas.com/company/baxter-innovations

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…